A more sensitive and specific radioenzymatic assay for catecholamines

Area of Science:

• Biochemistry
• Analytical Chemistry
• Pharmacology

Background:

• Catechol-O-methyltransferase (COMT) is crucial for metabolizing catecholamines like norepinephrine (NE) and epinephrine (E).
• Existing radioenzymatic assays for NE and E often suffer from low sensitivity and interference from COMT inhibitors present in biological samples.
• Accurate quantification of NE and E is vital for understanding various physiological and pathological conditions.

Purpose of the Study:

• To develop a modified radioenzymatic assay for norepinephrine (NE) and epinephrine (E) with improved sensitivity and selectivity.
• To eliminate common inhibitors of catechol-O-methyltransferase (COMT) from biological samples prior to analysis.
• To enable the detection and quantification of previously undetectable levels of plasma epinephrine (E).

Main Methods:

• Samples undergo a two-step extraction process using heptane with diphenylborate, followed by dilute acetic acid.
• This extraction efficiently isolates NE and E while removing COMT inhibitors like calcium.
• The modified assay utilizes catechol-O-methyltransferase (COMT) for sensitive radioenzymatic detection.

Main Results:

• The modified extraction procedure shows 78% efficiency for NE and <2% for S-adenosylmethionine (SAM).
• Assay sensitivity for NE and E in plasma is 10 pg/ml and 6 pg/ml, respectively.
• The assay successfully quantifies plasma E levels previously undetectable, with low intra- and inter-assay coefficients of variation.

Conclusions:

• The modified radioenzymatic assay offers enhanced sensitivity and selectivity for NE and E quantification.
• The improved extraction method effectively removes COMT inhibitors, simplifying standardization across different sample types.
• This assay advances the ability to measure critical catecholamine levels in biological fluids.